ES2135355A1 - Vacuna anti-vibrio anguillarum (gava-3) para la prevencion de la enfermedad vibriosis del rodaballo y peces salmonidos, y procedimiento de obtencion. - Google Patents

Vacuna anti-vibrio anguillarum (gava-3) para la prevencion de la enfermedad vibriosis del rodaballo y peces salmonidos, y procedimiento de obtencion.

Info

Publication number
ES2135355A1
ES2135355A1 ES09800889A ES9800889A ES2135355A1 ES 2135355 A1 ES2135355 A1 ES 2135355A1 ES 09800889 A ES09800889 A ES 09800889A ES 9800889 A ES9800889 A ES 9800889A ES 2135355 A1 ES2135355 A1 ES 2135355A1
Authority
ES
Spain
Prior art keywords
vaccine
turbot
gava
vibriosis
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09800889A
Other languages
English (en)
Other versions
ES2135355B1 (es
Inventor
Rodriguez Ysabel Santos
Toranzo Alicia Estevez
Perez Juan Luis Barja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidade de Santiago de Compostela
Original Assignee
Universidade de Santiago de Compostela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidade de Santiago de Compostela filed Critical Universidade de Santiago de Compostela
Priority to ES009800889A priority Critical patent/ES2135355B1/es
Priority to CA002294618A priority patent/CA2294618A1/en
Priority to EP99911820A priority patent/EP1001016A1/en
Priority to PCT/ES1999/000089 priority patent/WO1999055835A1/es
Publication of ES2135355A1 publication Critical patent/ES2135355A1/es
Priority to NO996428A priority patent/NO996428D0/no
Application granted granted Critical
Publication of ES2135355B1 publication Critical patent/ES2135355B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/63—Vibrio

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)

Abstract

Procedimiento de obtención de la vacuna GAVA-3 anti-Vibrio anguillarum para la prevención de la enfermedad vibriosis producida por la bacteria Vibrio anguillarum en rodaballo y peces salmónidos cultivados en agua de mar. El procedimiento se caracteriza por incluir en la vacuna las células bacterianas y los productos extracelulares inactivados con formol de tres cepas de Vibrio anguillarum pertenecientes a los serotipos O1 y O2, (subgrupos O2{al y O2{be ) (Cepas depositadasen la Colección Española de Cultivos Tipo, CECT, con los números de accesión CECT 5031, CECT 5032 y CECT 5033). La vacuna puede ser administrada por baño corto, baño prolongado opor inyección y confiere al rodaballo y peces salmónidos niveles notables de protección frente a la vibriosis.
ES009800889A 1998-04-27 1998-04-27 Vacuna anti-vibrio anguillarum (gava-3) para la prevencion de la enfermedad vibriosis del rodaballo y peces salmonidos, y procedimiento de obtencion. Expired - Fee Related ES2135355B1 (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ES009800889A ES2135355B1 (es) 1998-04-27 1998-04-27 Vacuna anti-vibrio anguillarum (gava-3) para la prevencion de la enfermedad vibriosis del rodaballo y peces salmonidos, y procedimiento de obtencion.
CA002294618A CA2294618A1 (en) 1998-04-27 1999-04-06 Anti-vibrio anguillarum vaccine (gava-3) for the prevention of the vibriosis disease in the turbot and salmonidae, and preparation process
EP99911820A EP1001016A1 (en) 1998-04-27 1999-04-06 ANTI-$i(VIBRIO ANGUILLARUM) VACCINE (GAVA-3) FOR THE PREVENTION OF THE VIBRIOSIS DISEASE IN THE TURBOT AND SALMONIDAE, AND PREPARATION PROCESS
PCT/ES1999/000089 WO1999055835A1 (es) 1998-04-27 1999-04-06 Vacuna anti-vibrio anguillarum (gava-3) para la prevencion de la enfermedad vibriosis en rodaballo y peces salmonidos, y procedimiento de obtencion
NO996428A NO996428D0 (no) 1998-04-27 1999-12-23 Anti-Vibrio anguillarum-vaksine (GAVA-3) for forhindring av vibriosen i piggvar og laksefisk og fremgangsmåten for fremstilling av slike vaksiner

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009800889A ES2135355B1 (es) 1998-04-27 1998-04-27 Vacuna anti-vibrio anguillarum (gava-3) para la prevencion de la enfermedad vibriosis del rodaballo y peces salmonidos, y procedimiento de obtencion.

Publications (2)

Publication Number Publication Date
ES2135355A1 true ES2135355A1 (es) 1999-10-16
ES2135355B1 ES2135355B1 (es) 2000-07-01

Family

ID=8303604

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009800889A Expired - Fee Related ES2135355B1 (es) 1998-04-27 1998-04-27 Vacuna anti-vibrio anguillarum (gava-3) para la prevencion de la enfermedad vibriosis del rodaballo y peces salmonidos, y procedimiento de obtencion.

Country Status (5)

Country Link
EP (1) EP1001016A1 (es)
CA (1) CA2294618A1 (es)
ES (1) ES2135355B1 (es)
NO (1) NO996428D0 (es)
WO (1) WO1999055835A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007128348A1 (en) * 2006-05-09 2007-11-15 Inve Technologies Nv Compositions comprising lytic enzymes of bacteriophages for treating bacterial infections
CN103275890A (zh) * 2013-05-03 2013-09-04 中国水产科学研究院黄海水产研究所 一株鳗弧菌（鳗利斯顿氏菌）强毒菌株及其应用
CN104138597B (zh) * 2013-05-07 2016-09-14 中国水产科学研究院黄海水产研究所 一种鳗弧菌二价疫苗及其制备和使用方法
CN110241057A (zh) * 2019-07-23 2019-09-17 福建九为生物技术有限公司 一种直投式蛭弧菌发酵剂及其制备方法和使用方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862313A (en) * 1974-01-17 1975-01-21 Us Interior Vibrio vaccine and immunization
JPS5423118A (en) * 1977-07-25 1979-02-21 Kitasato Inst Vaccine for bibrio disease of bred fish
JPS5699423A (en) * 1980-09-10 1981-08-10 Kitasato Inst:The Immune endowment to cultured fish by vaccine of vibrio disease

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862313A (en) * 1974-01-17 1975-01-21 Us Interior Vibrio vaccine and immunization
JPS5423118A (en) * 1977-07-25 1979-02-21 Kitasato Inst Vaccine for bibrio disease of bred fish
JPS5699423A (en) * 1980-09-10 1981-08-10 Kitasato Inst:The Immune endowment to cultured fish by vaccine of vibrio disease

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BASE DE DATOS WPI, semana 7913, Derwent Publications Ltd., Londres (GB), AN 79-24695B (13) & JP 54023118 A (KITASATO RES. INST.) 21.02.1979 *
BASE DE DATOS WPI, semana 8139, Derwent Publications Ltd., Londres (GB), AN 81-70566D (25) & JP 56099423 A (KITASATO RES. INST.) 10.08.1981 *
PRESS, C. y LILLEHAUG, A. Vaccination in European salmonid aquaculture: A Review of practices and prospects. Br. Vet. J. 1995. Vol. 151, paginas 45-69. *
SANTOS, Y. et al. Analysis of antigens present in the extracellular products and cell surface of Vibrio anguillarum serotypes 01,02 and 03. Applied and Environmental microbiology. 1995. Vol. 61, paginas 2493-2498. *
SANTOS, Y. et al. Protection of turbot, Scophthalmus maximus (L.), and rainbow trout, Oncorhynchus mykiss (Richardson) against vibriosis using two different vaccines. Journal of Fish Diseases. 1991. Vol. 14, paginas 407-411. *
TORANZO, A.E. et al. Immunization with bacterial antigens: Vibrio infections. En: Fish Vaccionology. Dev. Biol. Stand. Basel, Karger 1997. Vol. 90, paginas 93-105. *

Also Published As

Publication number Publication date
EP1001016A1 (en) 2000-05-17
NO996428L (no) 1999-12-23
ES2135355B1 (es) 2000-07-01
WO1999055835A1 (es) 1999-11-04
NO996428D0 (no) 1999-12-23
CA2294618A1 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
DE69533334T2 (de) Impfstoff zum Auflösen einer Immunreaktion auf ein tumorspezifisches Antigen
Kapperud et al. Plasmid-mediated surface fibrillae of Yersinia pseudotuberculosis and Yersinia enterocolitica: relationship to the outer membrane protein YOP1 and possible importance for pathogenesis
PT672116E (pt) Mutantes por supressao como vacinas contra a colera
ES2191052T3 (es) Vacuna polinucleotida contra el virus del papiloma.
ES2114565T3 (es) Lactobacilos colonizadores del intestino.
Bessler et al. The bacterial extract OM-85 BV protects mice against influenza and Salmonella infection
NZ291262A (en) E. coli heat-labile enterotoxin derivatives and their use as oral adjuvants
YU24391A (sh) Poboljšana meningokokna polisaharid kon-jugovana vakcina
HUP0303720A2 (hu) Egy immunstimuláns oligonukleotidot és egy tokolt tartalmazó adjuvánskészítmény
EP0793717A4 (en) ORAL IMMUNIZATION BY USING TRANSGENIC PLANTS
MX9708438A (es) Proteina principal de la membrana externa de moraxella, de alto peso molecular.
DE69425671D1 (de) Glucosamin-disaccharide, verfahren zu deren herstellung, pharmazeutische präparate davon und ihre verwendung
SE9600716L (sv) Adhesionsinhibitorer, preparat innehållande desamma och förfarande för framställning därav
SE9003198D0 (sv) Fish vaccine comprising a virulent, invasive bacterium
WO2001095933A3 (en) Immunization through oral administration of a vaccine with an edible product
ES469225A1 (es) Procedimiento para potenciar la accion de las vacunas.
CA2095534A1 (en) Avirulent microbes and uses therefor
ES2135355A1 (es) Vacuna anti-vibrio anguillarum (gava-3) para la prevencion de la enfermedad vibriosis del rodaballo y peces salmonidos, y procedimiento de obtencion.
BR9205677A (pt) Processo de produçao de uma composiçao de vacina contra infecçao entérica provocada por bactérias de E. COLI enterotoxigenicas, e, processo para evitar a infecçao entérica
EP1438066A4 (en) IMMUNOGENIC COMPOSITIONS OF ENTIRE CELLS OF REACTIVE BACTERIA
DE69330778T2 (de) Vogel-mycoplasmaantigen, sein gen, das gen enthaltender rekombinanter vektor, und damit hergestellter impfstoff
BG60275B1 (bg) Екстрацелуларен екзополимер с имуномодулаторни свойства, метод за получаването и приложението му
ES2115550A1 (es) Vacuna anti-pasteurella piscicida (di)para la prevencion de la enfermedad pasteurelosis en dorada y lubina y procedimiento de obtencion. .
FR2707168A1 (fr) Vaccin contre la dysenterie hémorragique du porc et ensemble de vaccination y relatif.
Sinha et al. Attenuation of virulence by P and V plasmids in Vibrio cholerae: strains suitable for oral immunization

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19991016

Kind code of ref document: A1

Effective date: 19991016

FD2A Announcement of lapse in spain

Effective date: 20180803